CHARACTERISTICS AND OUTCOMES OF CONTINUOUS RENAL REPLACEMENT THERAPY IN CHILDREN AT THE NATIONAL CHILDREN’S HOSPITAL
Main Article Content
Abstract
Objective: To describe characteristics, techniques, clinical conditions, and the outcomes of patients treated by continuous renal replacement therapy.
Subjects and methods: A cross-sectional descriptive study was conducted on 340 pediatric patients who underwent continuous renal replacement therapy (CRRT) at the Pediatric Intensive Care Unit, Vietnam National Children’s Hospital from January 2018 to June 2021.
Results: Sepsis was the most common conditions requrired CRRT (56.76%), followed by metabolic disorders (13.53%) and cardiogenic shock (8.24%). Continuous venovenous hemofiltration (CVVH) was the predominant modality (90.29%). The most common complications were hypokalemia (68.82%), filter clotting (52.06%), and hypotension (47.65%). The survival rate was 56.18%. Multivariable analysis showed that PELOD-2 score and the time from Intensive Care Unit admission to CRRT initiation were independently associated with mortality (p < 0.05).
Conclusions: CRRT is mainly used in pediatric patients for sepsis and multiple organ dysfunction. Although complications are common, they are generally manageable. Disease severity and timing of CRRT initiation are important factors influencing treatment outcomes.
Article Details
Keywords
Continuous renal replacement therapy, CRRT, pediatrics, complications, outcomes.
References
[2] Santiago M.J, López-Herce J, Urbano J et al. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care, 2009, 13: R184. doi: 10.1186/cc8172
[3] Kellum J.A, Lameire N (KDIGO AKI Guideline Work Grou). Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care, 2013, 17 (1): 204. doi: 10.1186/cc11454
[4] Zarbock A, Kellum J.A, Schmidt C et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA, 2016, 315 (20): 2190-2199. doi: 10.1001/jama.2016.5828
[5] Symons J.M, Chua A.N, Somers M.J et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clinical Journal of the American Society of Nephrology, 2007, 2 (4): 732-738. doi: 10.2215/CJN.03200906
[6] Ricci Z, Ronco C. Renal replacement therapy in the critically ill: getting it right. Current Opinion in Critical Care, 2012, 18 (6): 607-612. doi: 10.1097/MCC.0b013e328359fdb5
[7] Gaudry S, Hajage D, Schortgen F et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med, 2016, 375 (2): 122-133. doi: 10.1056/NEJMoa1603017
[8] Sutherland S.M, Zappitelli M, Alexander S.R et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis, 2010, 55 (2): 316-325. doi: 10.1053/j.ajkd.2009.10.048
[9] Leteurtre S, Duhamel A, Salleron J et al. PELOD-2: an update of the pediatric logistic organ dysfunction score. Crit Care Med, 2013, 41 (7): 1761-1773. doi: 10.1097/CCM.0b013e31828a2bbd